Jade Biosciences, Inc. (JBIO)
↓ Download CSVKey ratios (FY2025)
-38.3%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$113.54M | -$74.60M | -$81.41M | -$53.24M | -$23.02M | -$8.89M | — |
| Net Income | -$127.41M | -$69.63M | -$75.52M | -$51.51M | -$22.96M | -$9.61M | — |
| EPS (Diluted) | $-3.19 | $-2.44 | $-2.87 | $-2.10 | $-1.87 | — | — |
| Total Assets | $349.78M | $72.80M | $127.42M | $135.30M | $175.36M | $4.71M | — |
| Total Liabilities | $17.26M | $119.60M | $17.96M | $8.56M | $2.94M | $1.77M | — |
| Shareholders' Equity | $332.52M | -$46.80M | $109.46M | $126.74M | $172.42M | -$13.34M | -$3.64M |
| Cash & Equivalents | $88.44M | $69.39M | $23.49M | $22.40M | $54.20M | $4.57M | — |
| Operating Cash Flow | -$94.69M | -$71.20M | -$56.78M | -$39.12M | -$27.40M | -$7.86M | — |
| Capital Expenditures | $196.0K | — | $142.0K | $195.0K | $181.0K | — | — |
| Shares Outstanding | 49.32M | 3.67M | 27.76M | 24.72M | 24.41M | 243.1K | — |